OBSOLETE: Hereditary pediatric Behçet-like disease

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:476102
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Hereditary pediatric Behçet-like disease is a rare inherited condition that causes the immune system to become overactive, leading to widespread inflammation throughout the body. It shares many features with classic Behçet's disease — a well-known inflammatory condition — but it starts in childhood and is caused by changes (mutations) in specific genes rather than the complex mix of genetic and environmental factors seen in classic Behçet's. Because of this distinction, it is sometimes called 'monogenic Behçet-like disease' or 'pediatric autoinflammatory Behçet-like syndrome.' The disease mainly affects the lining of the mouth and gut, the skin, the eyes, and the joints. Children with this condition often experience painful sores in the mouth and digestive tract, skin rashes, eye inflammation, and recurring fevers. The immune system attacks the body's own tissues, causing repeated flares of symptoms that can be unpredictable. Note: This condition is listed as 'obsolete' in the Orphanet rare disease database, meaning it has been reclassified or merged into more specific diagnoses — such as ANCA-associated vasculitis or specific gene-defined autoinflammatory syndromes — as genetic understanding has improved. Treatment typically focuses on calming the immune system using anti-inflammatory and immunosuppressive medications.

Also known as:

Key symptoms:

Painful sores (ulcers) inside the mouthSores or ulcers in the digestive tract (gut)Skin rashes or soresEye inflammation (uveitis), which can cause redness, pain, or blurred visionRecurring fevers without an obvious infectionJoint pain and swellingAbdominal (belly) painDiarrhea, sometimes with bloodFatigue and low energySwollen lymph nodes

Inheritance

Variable

Can be inherited in different ways depending on the underlying gene

Age of Onset

Childhood

Begins in childhood, roughly ages 1 to 12

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for OBSOLETE: Hereditary pediatric Behçet-like disease.

View clinical trials →

No actively recruiting trials found for OBSOLETE: Hereditary pediatric Behçet-like disease at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the OBSOLETE: Hereditary pediatric Behçet-like disease community →

No specialists are currently listed for OBSOLETE: Hereditary pediatric Behçet-like disease.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to OBSOLETE: Hereditary pediatric Behçet-like disease.

Search all travel grants →NORD Financial Assistance ↗

Community

Open OBSOLETE: Hereditary pediatric Behçet-like diseaseForum →

No community posts yet. Be the first to share your experience with OBSOLETE: Hereditary pediatric Behçet-like disease.

Start the conversation →

Latest news about OBSOLETE: Hereditary pediatric Behçet-like disease

No recent news articles for OBSOLETE: Hereditary pediatric Behçet-like disease.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.Which specific gene mutation does my child have, and how does that affect treatment choices?,What are the early warning signs of a flare, and when should I bring my child to the emergency room?,How often should my child have eye exams, even when feeling well?,Are there clinical trials or specialized centers for this condition that we should consider?,What vaccinations are safe for my child while on immunosuppressive therapy?,How will this condition affect my child's growth and development long-term?,What support resources are available for our family?

Common questions about OBSOLETE: Hereditary pediatric Behçet-like disease

What is OBSOLETE: Hereditary pediatric Behçet-like disease?

Hereditary pediatric Behçet-like disease is a rare inherited condition that causes the immune system to become overactive, leading to widespread inflammation throughout the body. It shares many features with classic Behçet's disease — a well-known inflammatory condition — but it starts in childhood and is caused by changes (mutations) in specific genes rather than the complex mix of genetic and environmental factors seen in classic Behçet's. Because of this distinction, it is sometimes called 'monogenic Behçet-like disease' or 'pediatric autoinflammatory Behçet-like syndrome.' The disease mai

At what age does OBSOLETE: Hereditary pediatric Behçet-like disease typically begin?

Typical onset of OBSOLETE: Hereditary pediatric Behçet-like disease is childhood. Age of onset can vary across affected individuals.